Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Eli Lilly and Company Ltd
Woman and Man Max 99 years
Eli Lilly and Company Ltd
Update Il y a 4 ans
The DURABLE Trial: Assessing the DURAbility of Basal vs. Lispro Mix 25 Insulin Efficacy The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine when added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control
Initiation Phase The primary objective of the 6-month initiation phase of this study of patients with type 2 diabetes with inadequate glycemic control is to test the hypothesis that addition of twiced...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly and Company Ltd
Update Il y a 4 ans
Complaints Associated with Use of the Prefilled Pen B When Used by Patients with Type 2 Diabetes on Twice-Daily Insulin Therapy
The primary objective is to collect complaint data on the Prefilled Pen B when used by persons with type 2 diabetes to self-administer insulin in take-home situations for 2 months. These data will co...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eli Lilly and Company Ltd
Update Il y a 4 ans
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients with Type 2 Diabetes Mellitus: Two Populations with Different Insulin Treatment Options
The primary objectives are to test the hypothesis that: For insulin-naïve patients whose type 2 diabetes is not optimally controlled by 2 or more oral antihyperglycemic medications (including patient...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2